We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HealthEquity (HQY) completes the acquisition of Conduent's BenefitWallet HSA portfolio. This is likely to further strengthen the HSA business of HealthEquity.
Profound Medical's (PROF) Contouring Assistant integrates AI into prostate cancer procedures, thereby streamlining the treatment planning process and enhancing both efficiency and precision.
Thermo Fisher's (TMO) new Applied Biosystems Axiom BloodGenomiX Array and Software provide a high-throughput solution for more precise blood matching research.
Henry Schein's (HSIC) extended collaboration with Special Olympics is likely to promote wellness and health education for athletes with ID around the world.
Stereotaxis' (STXS) deal to acquire electrophysiology catheter developer, Access Point Technologies, is likely to strengthen its position within the catheter market.
Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.
Philips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power malfunction and gets FDA Class I recall identification, as it may cause serious harm.
medical-devices: Archive
Butterfly Network (BFLY) Unveils iQ+ Bladder Ultrasound Scanner
by Zacks Equity Research
Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.
DVANegative Net Change ALGNNegative Net Change MEDPNegative Net Change BFLYNegative Net Change
medical medical-devices
Three Reasons to Retain AMN Healthcare (AMN) Stock for Now
by Zacks Equity Research
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.
ECLNegative Net Change DVANegative Net Change AMNNegative Net Change VEEVNegative Net Change
medical medical-devices
HealthEquity (HQY) Closes Conduent's BenefitWallet Acquisition
by Zacks Equity Research
HealthEquity (HQY) completes the acquisition of Conduent's BenefitWallet HSA portfolio. This is likely to further strengthen the HSA business of HealthEquity.
BSXPositive Net Change ECLNegative Net Change ALGNNegative Net Change HQYPositive Net Change
medical medical-devices
Great Southern Bancorp (GSBC)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
GSBCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Labcorp (LH) to Assess Preeclampsia Risk With New Test
by Zacks Equity Research
Labcorp's (LH) new first-trimester test is the latest addition to its dedication to improving women's health.
LHNegative Net Change RMDNegative Net Change MEDPNegative Net Change EHCNegative Net Change
medical medical-devices
Profound Medical (PROF) Adds AI to Prostate Cancer Treatment
by Zacks Equity Research
Profound Medical's (PROF) Contouring Assistant integrates AI into prostate cancer procedures, thereby streamlining the treatment planning process and enhancing both efficiency and precision.
DVANegative Net Change ALGNNegative Net Change MEDPNegative Net Change PROFNegative Net Change
medical medical-devices
Thermo Fisher (TMO) Unveils New Extended Blood Genotyping Array
by Zacks Equity Research
Thermo Fisher's (TMO) new Applied Biosystems Axiom BloodGenomiX Array and Software provide a high-throughput solution for more precise blood matching research.
TMONegative Net Change MEDPNegative Net Change HIMSPositive Net Change HITINo Net Change
medical medical-devices
Here's Why Investors Should Retain QIAGEN (QGEN) Stock Now
by Zacks Equity Research
QIAGEN's (QGEN) solid potential in the NGS platform buoys optimism for investors.
QGENPositive Net Change MEDPNegative Net Change HIMSPositive Net Change HITINo Net Change
medical medical-devices
Here's Why You Should Retain Henry Schein (HSIC) Stock for Now
by Zacks Equity Research
Investors are optimistic about Henry Schein (HSIC), owing to strategic acquisitions and potential in Henry Schein One.
RMDNegative Net Change HSICNegative Net Change MEDPNegative Net Change EHCNegative Net Change
medical medical-devices
Merit Medical (MMSI) to Expand Product Suite Via New Launch
by Zacks Equity Research
Merit Medical's (MMSI) latest additions to its embolotherapy portfolio are likely to improve the patient experience.
ECLNegative Net Change DVANegative Net Change MMSINegative Net Change VEEVNegative Net Change
medical medical-devices
Reasons to Add Veeva Systems (VEEV) Stock to Your Portfolio
by Zacks Equity Research
Veeva System's (VEEV) strong product demand and strategic deals raise optimism about the stock.
BSXPositive Net Change ECLNegative Net Change ALGNNegative Net Change VEEVNegative Net Change
medical medical-devices
GE HealthCare (GEHC), Medis Medical Partner to Aid CAD Therapy
by Zacks Equity Research
GE HealthCare (GEHC) and Medis Medical collaborate to boost precision care for coronary artery disease treatment.
BSXPositive Net Change ECLNegative Net Change ALGNNegative Net Change GEHCNegative Net Change
medical medical-devices
Here's Why You Should Buy Align Technology (ALGN) Stock Now
by Zacks Equity Research
Investors are optimistic about Align Technology (ALGN) led by expansion in new geographies and upbeat guidance.
ALGNNegative Net Change RMDNegative Net Change MEDPNegative Net Change EHCNegative Net Change
medical medical-devices
QIAGEN's (QGEN) QCI Interpret Gets European IVDR Certification
by Zacks Equity Research
QIAGEN's (QGEN) Clinical Insight Interpret is the first NGS interpretation platform approved by IVDR for use in cancer and hereditary applications.
RMDNegative Net Change QGENPositive Net Change MEDPNegative Net Change EHCNegative Net Change
medical medical-devices
3 Solid Buys From MedTech Following 2024 Guidance Raise
by Urmimala Biswas
Guidance hikes by BSX, ALGN and ALC for 2024 make them attractive investment bets.
BSXPositive Net Change ALGNNegative Net Change ALCNegative Net Change
earnings medical medical-devices
Henry Schein (HSIC) Extends Partnership With Special Olympics
by Zacks Equity Research
Henry Schein's (HSIC) extended collaboration with Special Olympics is likely to promote wellness and health education for athletes with ID around the world.
RMDNegative Net Change HSICNegative Net Change HIMSPositive Net Change HITINo Net Change
medical medical-devices
Here's Why You Should Retain Zimmer Biomet (ZBH) Stock for Now
by Zacks Equity Research
Strong procedure recovery and progress on the four-pillar strategy bode well for Zimmer Biomet (ZBH).
ZBHPositive Net Change MEDPNegative Net Change HIMSPositive Net Change HITINo Net Change
medical medical-devices
Senseonics' (SENS) Deal With Mercy to Drive Eversense CGM Sales
by Zacks Equity Research
Senseonics Holdings (SENS) collaborates with Mercy to bring its Eversense CGM to a healthcare system that is likely to drive its adoption.
DVANegative Net Change ALGNNegative Net Change SENSNegative Net Change MEDPNegative Net Change
medical medical-devices
Stereotaxis (STXS) Inks Deal to Buy Access Point Technologies
by Zacks Equity Research
Stereotaxis' (STXS) deal to acquire electrophysiology catheter developer, Access Point Technologies, is likely to strengthen its position within the catheter market.
DVANegative Net Change ALGNNegative Net Change STXSNo Net Change MEDPNegative Net Change
medical medical-devices
Alcon (ALC) Q1 Earnings Surpass Estimates, Margins Expand
by Zacks Equity Research
Alcon's (ALC) Q1 results reflect substantial growth in its franchises on the back of healthy markets.
RMDNegative Net Change ALCNegative Net Change MEDPNegative Net Change EHCNegative Net Change
earnings medical medical-devices
Baxter's (BAX) Clinolipid Gets FDA's Expanded Indication
by Zacks Equity Research
Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.
ECLNegative Net Change BAXNegative Net Change DVANegative Net Change VEEVNegative Net Change
medical medical-devices
Glaukos (GKOS) Reaches 52-Week High: What's Aiding the Stock?
by Zacks Equity Research
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.
ECLNegative Net Change DVANegative Net Change VEEVNegative Net Change GKOSNegative Net Change
medical medical-devices
Philips' (PHG) Gets FDA Recall for Trilogy Ventilator Glitch
by Zacks Equity Research
Philips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power malfunction and gets FDA Class I recall identification, as it may cause serious harm.
BSXPositive Net Change ECLNegative Net Change PHGPositive Net Change ALGNNegative Net Change
medical medical-devices
QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus
by Zacks Equity Research
QIAGEN (QGEN) receives FDA clearance for the QIAstat-Dx respiratory syndromic testing panel for fast and accurate results.
RMDNegative Net Change QGENPositive Net Change HIMSPositive Net Change HITINo Net Change
medical medical-devices
Should You Buy Newmont Corporation (NEM) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
NEMNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines